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The effect of endothelin (ET) on rat cardiac myocytes cultured in a serum-free, defined medium was determined. ET stimulated cardiac myocyte 
hypertrophy in a dose-dependent manner as determined by the protein synthesis and cell surface area. Since the myocyte hypertrophy was abolished 
by H-7, a protein kinase C inhibitor, ET-receptor mediated protein kinase C activation may be involved in cardiac myocyte hypertrophy. At the 
same time, ET also stimulated myocyte contractility in this medium, and this stimulatory effect was inhibited by nicardipine. This result indicates 
that the influx of extracellular calcium ion is necessary for the stimulation of contractility induced by ET. 
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1. INTRODUCTION 2.2. Cell isolation and primary cell cultures of neonatal rat cardiac 
myocytes 
Endothelin (ET), a novel vasoconstrictor peptide 
originally isolated from the culture supernatant of por- 
cine aortic endothelial cells, is composed of 21 amino 
acid residues with two intramolecular disulfide linkages 
[l]. ET displays powerful vasoconstrictive [l] and car- 
diatonic properties [2]. ET possesses potent inotropic 
and chronotropic actions on isolated atria in humans 
[3,4], guinea pigs [3] and rats [2,4]. Furthermore, ET 
receptors in cardiac membrane [5] and in cultured heart 
cells [6,7] have been characterized. These reports sug- 
gest that ET exerts direct physiological role on cardiac 
myocytes. In this report, we have attempted to 
elucidate the stimulation of hypertrophy and contrac- 
tility of ET on cardiac myocytes in a serum-free, defin- 
ed culture medium. 
Ventricular cardiac muscle cells (myocytes) were isolated from 
I-3-day-old male Wistar rats as previously described [9]. The 
isolated cells were maintained in a serum-free, defined medium, 
MCDB 107 supplemented with 10 pg/ml of insulin and transferrin, 
on 24-well culture plates precoated with 10 fig/ml of fibronectin, and 
used within a week. 
2.3. Assay of protein synthesis 
There are increases in protein synthesis and in cell surface area of 
cardiac myocytes during myocyte hypertrophy [lo, 111. To determine 
the increase of cardiac cell size (hypertrophy), protein synthesis was 
measured by monitoring the incorporation of [*4C]leucine into the 
trichloroacetic acid-insoluble materials as described previously 191. 
2.4. Measurements of rhythmic contraction of cardiac myocytes 
Beating rate and beating cell number of the cells were determined 
as described in a previous procedure [9]. 
3. RESULTS 
2. MATERIALS AND METHODS 
2.1. Materials 
Nutrient medium MCDB 107 was a gift from Kyokuto Phar- 
maceutical Industrial Co. (Tokyo, Japan). Endothelin-1 was obtain- 
ed from Peptide Institute, Inc. (Osaka, Japan). Collagenase was 
obtained from Wako Pure Chemical Co. (Tokyo, Japan). Insulin, 
human apo-transferrin, trypsin (Type XII, x 2 crystallized), nicar- 
dipine hydrochloride were purchased from Sigma. H-7 was obtained 
from Seikagaku Kogyo Inc. (Tokyo, Japan). [14C]Leucine 
(12 GBq/mmol) was from Amersham. Fibronectin was prepared 
from bovine plasma according to the method of Vuento et al. [8]. 
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ET increased the protein synthesis of cardiac 
myocytes in a dose-dependent manner, and the half- 
maximum dose was 170 pM (Fig. 1). The threshold 
concentration for ET-induced protein synthesis was ap- 
proximately 100 pM whereas the maximum effect of 
protein synthesis occurred at 1 nM of the peptide. 
Following the stimulation of protein synthesis, the in- 
crease of cell surface area has been observed in the 
presence of ET (Fig. 2B). The cell surface area increas- 
ed by 1 nM of ET was about 3-4-fold of the control 
cultures. While a high dose of nicardipine (1 PM) in- 
dicated a slightly inhibitory effect to ET-induced pro- 
tein synthesis (Fig. 3), the inhibitory effect by 
nicardipine on ET-induced myocyte hypertrophy was 
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Fig. 1. Dose-dependent stimulation by ET on the incorporation of 
[‘klleucine into myocardial cell protein. Data are expressed as the 
percent increase of the control cultures (1615 f 70 dpm/lO’ cells). 
Values are the mean + SE of triplicate cultures from 3 independent 
experiments. 
less effective (Fig. 2C). In contrast, H-7, a protein 
kinase C inhibitor, strongly attenuated the ET-induced 
protein synthesis in a dose-competitive manner (Fig. 3). 
Moreover, ET-induced myocyte hypertrophy was 
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Fig. 3. Effect of nicardipine and H-7 on the incorporation of 
[?Z]leucine into myocardial cell protein stimulated by ET. Data are 
expressed as the percent of the control cultures (1538 f 25/10’ cells). 
Values are the mean k SE of triplicate cultures from 3 independent 
experiments. 
markedly attenuated in the presence of H-7 (1OOpM) 
(Fig. 2D). 
Cultured cardiac myocytes hardly elicited the 
rhythmic contraction in this serum-free medium (Table 
I). However, the addition of ET (1 nM) made the 
myocytes stable and elicited powerful rhythmic con- 
traction. A dose-dependent inhibition of nicardipine 
was observed on ET-induced rhythmic contraction of 
myocytes and complete inhibition was shown at a dose 
of 0.1 ,uM. 
Fig. 2. Hypertrophic stimulation of ET on cultured cardiac myocytes and the effect of nicardipine and H-7 in the presence of maximal dose (1 nM) 
of ET. Cells were photographed 48 h after incubation with different test samples. (A) Control; (B) ET (1 nM); (C) ET (1 nM) + nicardipine 
(1 pM); (D) ET (1 nM) + H-7 (1OOcM). Magnification x 52.5. 
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Table 1 
Dose-dependent inhibition of nicardipine (NP) on the rhythmic 
contraction of cardiac myocytes stimulated by endothelin (ET) 
Factor added Beating 
Cells (S) Rate (min-‘) 
No supplement 2.7 i 1.3 15.4 * 4.8 
ET 1 nM 91.3 If: 5.2 136.9 + 10.5 
ET (1 nM) + NP (0.01 PM) 63.0 f 7.5 96.6 f 7.5 
ET (1 nM) + NP (0.1 PM) 7.5 f 2.8 19.4 f 6.7 
ET (1 nM) + NP (1 PM) 0.9 rt 0.5 9.1 + 2.8 
Values are the mean f SE 
4. DISCUSSION 
Myocyte hypertrophy results in an increase in 
myocardial cell size, sarcomere number, and myocar- 
dial protein content [10,12]. This is the first report that 
ET stimulated cardiac myocyte hypertrophy as 
qualified by the protein synthesis and cell surface area 
of cultured cardiac myocytes in a serum-free medium. 
The ET-induced myocyte h~ertrophy was only partial- 
ly attenuated by a voltage-dependent calcium channel 
blocker, nicardipine. This may suggest that voltage- 
dependent calcium channel activation is not directly in- 
volved in the development of cardiac myocyte hyper- 
trophy. Simpson and co-workers [ 10,121 demonstrated 
that cardiac myocyte hypertrophy was induced by 
norepinephrine and serum in neonatal rat heart cells in 
a serum-free medium, and the hypertrophy induced by 
norepinephrine was mediated through an cul-adrenergic 
receptor [ 11,121. Stimulation of ai-adrenergic recep- 
tors results in the accumulation of inositol phosphates 
and diacylglycerol in cardiac myocytes [13]. Further- 
more, increased level of c-myc protooncogene expres- 
sion was associated with cardiac myocyte hypertrophy 
caused by norepinephrine and serum [I41 as well as a 
physical load [ 151. There are reports that ET stimulates 
c-myc and c-fos gene expression [161 and diacylglycerol 
accumulation activating protein kinase C [17] in 
cultured vascular smooth muscle cells. In the present 
study, H-7, a protein kinase C inhibitor, completely 
abolished the ET-induced increase of protein synthesis 
and myocyte h~ertrophy. This suggests that receptor- 
mediated protein kinase C activation may be involved 
in the ET-induced cardiac myocyte h~ertrophy. At the 
same time, the rhythmic contraction was elicited by ET 
in the cultured cardiac myocytes. The molecular 
mechanism of the stimulation of contractility induced 
by ET has not been clearly understood. Recent study 
has demonstrated that ET induced the phospholipase 
C-mediated hydrolysis of phosphoinositides followed 
by the release of calcium from calcium ion stores in 
rabbit aortic smooth muscle cells [18]. Furthermore, 
Vigne et al. [19] reported that the inotropic effect of ET 
involves hydrolysis of phosphatidyIinosito1. And they 
also reported that since the effect of ET on rat atrium 
was antagonized by a calcium channel blocker, low ex- 
ternal calcium ion concentration and also drugs that in- 
terfere with calcium ion release by the sarcoplasmic 
reticulum, the inotropic effect of ET involved both 
calcium ion entry through L-type calcium ion channels 
and calcium ion release from the sarcoplasmic 
reticulum 1191. We also found that ET-induced 
rhythmic contraction of cardiac myocytes was strongly 
attenuated by nicardipine. This finding suggests that in- 
flux of extracellular calcium is required for the contrac- 
tile action of ET. 
In summary, receptor-mediated phospholipase C ac- 
tivation followed by protein kinase C activation may be 
involved in the development of cardiac myocyte hyper- 
trophy. At the same time, the receptor-mediated 
phospholipase C activation followed by phosphatidyl- 
inositol hydrolysis and calcium mobilization may be in- 
volved in the contractile activation of ET in cultured 
cardiac myocytes. 
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